Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.
1 |
Alminoja A et al. |
Does Decision-making in End-of-life Care Differ Between Graduating Medical Students and Experienced Physicians?
|
2 |
Araque O et al. |
Selecting the Mammographic-View for the Parenchymal Analysis-Based Breast Cancer Risk Assessment.
|
3 |
Aula H et al. |
Transforming growth factor beta 1 levels predict echocardiographic changes at three years after adjuvant radiotherapy for breast cancer.
|
4 |
Auvray M et al. |
Second-line targeted therapies after nivolumab-ipilimumab failure in metastatic renal cell carcinoma.
|
5 |
Bärlund M, Mattson J. |
Syöpäpotilaan sähköiset seurantamenetelmät.
|
6 |
Escala-Garcia M et al. |
Genome-wide association study of germline variants and breast cancer-specific mortality.
|
7 |
Escala-Garcia M et al. |
Genome-wide association study of germline variants and breast cancer-specific mortality.
|
8 |
Forsgård RA et al. |
Two-Week Aflibercept or Erlotinib Administration Does Not Induce Changes in Intestinal Morphology in Male Sprague-Dawley Rats But Aflibercept Affects Serum and Urine Metabolic Profiles.
|
9 |
Hackman G et al. |
Randomised Trial of Adjuvant Radiotherapy Following Radical Prostatectomy Versus Radical Prostatectomy Alone in Prostate Cancer Patients with Positive Margins or Extracapsular Extension.
|
10 |
Hirvonen OM et al. |
Assessing the utilization of the decision to implement a palliative goal for the treatment of cancer patients during the last year of life at Helsinki University Hospital: a historic cohort study.
|
11 |
Hosio M et al. |
Association of antidiabetic medication and statins with breast cancer incidence in women with type 2 diabetes.
|
12 |
Jansen YJL et al. |
Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma.
|
13 |
Jääskeläinen A et al. |
Cytoplasmic Mineralocorticoid Receptor Expression Predicts Dismal Local Relapse-free Survival in Non-triple-negative Breast Cancer.
|
14 |
Jääskeläinen A et al. |
Elevated preoperative serum levels of collagen I carboxyterminal telopeptide predict better outcome in early-stage luminal-B-like (HER2-negative) and triple-negative subtypes of breast cancer.
|
15 |
Kaidar-Person O et al. |
ESTRO ACROP consensus guideline for target volume delineation in the setting of postmastectomy radiation therapy after implant-based immediate reconstruction for early stage breast cancer.
|
16 |
Kaikkonen E et al. |
ANO7 rs77559646 Is Associated With First-line Docetaxel Treatment Response in Metastatic Castration-resistant Prostate Cancer.
|
17 |
Kaikkonen E et al. |
ANO7 rs77559646 Is Associated With First-line Docetaxel Treatment Response in Metastatic Castration-resistant Prostate Cancer.
|
18 |
Kaikkonen E et al. |
rs77559646 Is Associated With First-line Docetaxel Treatment Response in Metastatic Castration-resistant Prostate Cancer.
|
19 |
Kellokumpu-Lehtinen P-L, Joensuu T. |
Nya vindar inom behandlingen av prostatacancer.
|
20 |
Kellokumpu-Lehtinen PL et al. |
Docetaxel Versus Surveillance After Radical Radiotherapy for Intermediate- or High-risk Prostate Cancer : Results from the Prospective, Randomised, Open-label Phase III SPCG-13 Trial.
|
21 |
Kokkonen K et al. |
Cancer Patients' Symptom Burden and Health-related Quality of Life (HRQoL) at Tertiary Cancer Center from 2006 to 2013: A Cross-sectional Study.
|
22 |
Koski K et al. |
Physician self-disclosure and vaccine-critical parents' trust : Preparing medical students for parents' difficult questions.
|
23 |
Laaksomaa M et al. |
AlignRT® and CatalystTM in whole-breast radiotherapy with DIBH: Is IGRT still needed?
|
24 |
Lehto J et al. |
Elämän loppuvaiheen ennakoiva hoitosuunnitelma.
|
25 |
Lehto U et al. |
Early quality-of-life and psychological predictors of disease-free time and survival in localized prostate cancer.
|
26 |
Lehtomäki K et al. |
Clonal Evolution of MEK/MAPK Pathway Activating Mutations in a Metastatic Colorectal Cancer Case.
|
27 |
Leivonen SK et al. |
T-cell inflamed tumor microenvironment predicts favorable prognosis in primary testicular lymphoma.
|
28 |
Loi S et al. |
Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers.
|
29 |
Mannisto S et al. |
Intravenous but not intrathecal central nervous system-directed chemotherapy improves survival in patients with testicular diffuse large B-cell lymphoma.
|
30 |
Mattila KE et al. |
Combination chemotherapy with temozolomide, lomustine, vincristine and interferon-alpha (TOL-IFN) plus vemurafenib or TOL-IFN as first-line treatment for patients with advanced melanoma.
|
31 |
Mavaddat N et al. |
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.
|
32 |
Motzer RJ et al. |
Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial.
|
33 |
Orell H et al. |
Nutritional Counseling for Head and Neck Cancer Patients Undergoing (Chemo) Radiotherapy-A Prospective Randomized Trial.
|
34 |
Partanen A et al. |
Comparison of filgrastim, pegfilgrastim, and lipegfilgrastim added to chemotherapy for mobilization of CD34.
|
35 |
Penttinen H, Sormunen J. |
Liikunnan vaikutus syövän ehkäisyyn ja sairastuneiden kuolleisuuteen.
|
36 |
Penttinen H et al. |
Effectiveness of a 12-month Exercise Intervention on Physical Activity and Quality of Life of Breast Cancer Survivors; Five-year Results of the BREX-study.
|
37 |
Pertuz S et al. |
Do Mammographic Systems Affect the Performance of Computerized Parenchymal Analysis?
|
38 |
Pertuz S et al. |
Micro-parenchymal Patterns for Breast Cancer Risk Assessment.
|
39 |
Piili R. |
End-of-Life Decision-Making in Cancer Patients : Attitudes, ethics and background factors among Finnish physicians and medical students.
|
40 |
Prusila REI et al. |
Risk of secondary haematological malignancies in patients with follicular lymphoma: an analysis of 1028 patients treated in the rituximab era.
|
41 |
Rantala HA et al. |
Predictors of Impaired Survival in Subjects With Long-Term Oxygen Therapy.
|
42 |
Reijonen P et al. |
Histologically Verified Biliary Invasion was Associated with Impaired Liver Recurrence-Free Survival in Resected Colorectal Cancer Liver Metastases.
|
43 |
Rossi M et al. |
Optimal selection of optimization bolus thickness in planning of VMAT breast radiotherapy treatments.
|
44 |
Saarto T, Lehto J. |
Palliatiivisen hoidon ja saattohoidon järjestäminen Suomessa - kolmiportainen malli.
|
45 |
Salminen V. |
Uskaltaako potilaasi kertoa sinulle käyttämistään hoidoista?
|
46 |
Skyttä T, Mäenpää H. |
Sädehoidon haittavaikutukset.
|
47 |
Skyttä T et al. |
Adjuvant radiotherapy-induced cardiac changes among patients with early breast cancer: a three-year follow-up study.
|
48 |
Sorigue M et al. |
Incidence of solid cancer in patients with follicular lymphoma.
|
49 |
Soveri LM et al. |
Long-term neuropathy and quality of life in colorectal cancer patients treated with oxaliplatin containing adjuvant chemotherapy.
|
50 |
Takala L et al. |
Effective Antiemetic Therapy Is Important With Adjuvant Anthracycline-based Chemotherapy in Breast Cancer.
|
51 |
Talibov M et al. |
Workplace Diesel Exhausts and Gasoline Exposure and Risk of Colorectal Cancer in Four Nordic Countries.
|
52 |
Terkamo-Moisio A et al. |
Attitudes of Nurses and the General Public Towards Euthanasia on Individuals with Dementia and Cognitive Impairment.
|
53 |
Terävä J et al. |
Lectin nanoparticle assays for detecting breast cancer-associated glycovariants of cancer antigen 15-3 (CA15-3) in human plasma.
|
54 |
Tiainen L et al. |
Low Plasma IL-8 Levels During Chemotherapy Are Predictive of Excellent Long-Term Survival in Metastatic Breast Cancer.
|
55 |
Tiainen L et al. |
High baseline Tie1 level predicts poor survival in metastatic breast cancer.
|
56 |
Torres GF et al. |
Morphological Area Gradient: System-independent Dense Tissue Segmentation in Mammography Images.
|
57 |
Tuohinen S et al. |
Syöpäpotilaan sydän - tutkimukset ja hoidon optimointi.
|
58 |
Tuohinen SSirkku et al. |
Left Ventricular Speckle Tracking Echocardiography Changes Among Early-stage Breast Cancer Patients Three Years After Radiotherapy.
|
59 |
Vuorinen R et al. |
Sunitinib First-line Treatment in Metastatic Renal Cell Carcinoma: Costs and Effects.
|
60 |
Vähämurto P et al. |
Clinical features and outcome of the patients with sinonasal tract diffuse large B-cell lymphoma in the pre-rituximab and rituximab eras.
|
61 |
Winther S et al. |
Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full-dose monotherapy (S-1) in older vulnerable patients with metastatic colorectal cancer (NORDIC9): a randomised, open-label phase 2 trial.
|
62 |
Wu X et al. |
Monitoring radiotherapy induced tissue changes in localized prostate cancer by multi-parametric magnetic resonance imaging (MP-MRI).
|